ML21130A632

From kanterella
Jump to navigation Jump to search
Shine Medical Technologies, LLC, Submittal of Application for an Operating License Response to Request for Additional Information
ML21130A632
Person / Time
Site: SHINE Medical Technologies
Issue date: 04/30/2021
From: Jim Costedio
SHINE Medical Technologies
To:
Document Control Desk, Office of Nuclear Reactor Regulation
References
2021-SMT-0054
Download: ML21130A632 (2)


Text

1.

SAFEGUARDS INFORMATION April 30, 2021 2021-SMT-0054 10 CFR 50.30 U.S. Nuclear Regulatory Commission*

ATTN: Document Control Desk Washington, DC 20555

References:

(1) SHINE Medical Technologies, LLC letter to the NRG, "SHINE Medical Technologies, LLC Application for an Operating License," dated July 17, 2019 (ML19211C143)

(2) SHINE Medical Technologies, LLC letter to the NRG, "SHINE Medical Technologies, LLC Submittal of the SHINE Physical Security Plan," dated July 17, 2019 (ML19200A030)

(3) NRG letter to SHINE Medical Technologies, LLC, "SHINE Medical Technologies, LLC - Request for Additional Information Related Meteorological Data, Cooling Systems, and Physical Security Plan (EPID No. L-2019-NEW-0004)," dated April 8, 2021 (ML21089A000)

SHINE Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information Pursuant to 10 CFR Part 50.30, SHINE Medical Technologies, LLC (SHINE) submitted an application for an operating license for a medical isotope production facility to be located in Janesville, WI (Reference 1 ). In support of the SHINE application for an operating license for a medical isotope production facility, SHINE submitted the Physical Security Plan under separate cover (Reference 2). The NRC staff determined that additional information was required to enable the staffs continued review the SHINE Physical Security Plan (Reference 3). provides the SHINE response to the NRC staffs request for additional information. 1contains safeguards information, as defined in 10 CFR 73.2. SHINE requests that the NRG withhold Enclosure 1 from unauthorized disclosure under 10 CFR 73.21.

If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.

  • WHEN SEPARATED FROM THE ENCLOSURE SAFEGUARDS 1.NFORMATION, THIS LETTER IS UNCONTROLLED 101 E. Milwaukee St., Suite 600 I Janesville, WI 535451 P (608) 210-1060 IF (608) 210-2504 I www.shinemed.com SAFEGUARDS INFORMATION

Document Control Desk Page 2 SAFEGUARDS INFORMATION I declare under the penalty of perjury that the foregoing is true and correct.

Executed on April 30, 2021.

Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Medical Technologies, LLC Docket No. 50-608 Enclosure WHEN SEPARATED FROM THE ENCLOSURE SAFEGUARDS INFORMATION, THIS LETTER IS UNCONTROLLED SAFEGUARDS INFORMATION